|
US2014057984A1
|
|
Methods of treating corticobasal degeneration comprising administering metal chelators to the upper one-third of the nasal cavity
|
|
US2014179789A1
|
|
Methods of treating Huntington's disease comprising administering metal chelators to the upper one-third of the nasal cavity
|
|
CA2801581A1
|
|
Methods and pharmaceutical compositions for treating the animal central nervous system for psychiatric disorders
|
|
WO2008154337A1
|
|
Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system
|
|
US2007092500A1
|
|
Method of treating Alzheimer's disease comprising administering deferoxamine (DFO) to the upper one-third of the nasal cavity
|
|
US2006039995A1
|
|
Methods for providing neuroprotection for the animal central nervous system against neurodegeneration caused by ischemia
|
|
US7084126B1
|
|
Methods and compositions for enhancing cellular function through protection of tissue components
|
